A detailed history of Castleview Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Castleview Partners, LLC holds 10,850 shares of AMGN stock, worth $2.97 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares
10,850
Previous 11,562 6.16%
Holding current value
$2.97 Million
Previous $3.01 Million 6.17%
% of portfolio
1.87%
Previous 2.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

SELL
$258.78 - $328.31 $184,251 - $233,756
-712 Reduced 6.16%
10,850 $2.83 Million
Q3 2024

Oct 21, 2024

BUY
$309.38 - $337.38 $580,706 - $633,262
1,877 Added 19.38%
11,562 $3.73 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $49,397 - $60,030
188 Added 1.98%
9,685 $3.03 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $1.78 Million - $2.15 Million
6,620 Added 230.1%
9,497 $2.7 Million
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $119,156 - $134,422
466 Added 19.33%
2,877 $828,000
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $104,952 - $130,300
480 Added 24.86%
2,411 $647,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $56,995 - $67,396
-266 Reduced 12.11%
1,931 $428,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $496,060 - $604,614
2,197 New
2,197 $531,000
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $94,273 - $106,323
420 Added 116.67%
780 $176,000
Q2 2022

Aug 17, 2022

SELL
$230.71 - $256.74 $45.3 Million - $50.4 Million
-196,469 Reduced 99.82%
360 $87,000
Q2 2022

Aug 16, 2022

BUY
$230.71 - $256.74 $45.2 Million - $50.3 Million
195,968 Added 22760.51%
196,829 $47.9 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $49.5 Million - $54.8 Million
-225,908 Reduced 99.62%
861 $208,000
Q4 2021

Feb 17, 2022

BUY
$198.88 - $227.6 $44.9 Million - $51.4 Million
226,011 Added 29816.75%
226,769 $51 Million
Q2 2021

Aug 17, 2021

BUY
$233.58 - $259.14 $177,053 - $196,428
758 New
758 $185,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.